BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 17387235)

  • 1. Glucose dysregulation in nondiabetic patients with ST-elevation myocardial infarction: acute and chronic glucose dysregulation in STEMI.
    Rasoul S; Ottervanger JP; Bilo HJ; Timmer JR; van 't Hof AW; Dambrink JH; Dikkeschei LD; Hoorntje JC; de Boer MJ; Zijlstra F
    Neth J Med; 2007 Mar; 65(3):95-100. PubMed ID: 17387235
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Optimal glucose, HbA1c, glucose-HbA1c ratio and stress-hyperglycaemia ratio cut-off values for predicting 1-year mortality in diabetic and non-diabetic acute myocardial infarction patients.
    Sia CH; Chan MH; Zheng H; Ko J; Ho AF; Chong J; Foo D; Foo LL; Lim PZ; Liew BW; Chai P; Yeo TC; Tan HC; Chua T; Chan MY; Tan JWC; Bulluck H; Hausenloy DJ
    Cardiovasc Diabetol; 2021 Oct; 20(1):211. PubMed ID: 34666746
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Prognostic value of HbA1c and plasma glucose on one-year mortality in non-diabetic patients after myocardial infarction].
    Gueniat-Ratheau E; Yao H; Debeaumarche H; Maalem B; Lairet C; Maza M; Bichat F; Zeller M; N'Guetta R; Cottin Y
    Ann Cardiol Angeiol (Paris); 2020 Oct; 69(4):180-191. PubMed ID: 32854906
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic value of admission glycosylated hemoglobin and glucose in nondiabetic patients with ST-segment-elevation myocardial infarction treated with percutaneous coronary intervention.
    Timmer JR; Hoekstra M; Nijsten MW; van der Horst IC; Ottervanger JP; Slingerland RJ; Dambrink JH; Bilo HJ; Zijlstra F; van 't Hof AW
    Circulation; 2011 Aug; 124(6):704-11. PubMed ID: 21768543
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hemoglobin A1c and short-term outcomes in patients with acute myocardial infarction undergoing primary angioplasty: an observational multicenter study.
    Tian L; Zhu J; Liu L; Liang Y; Li J; Yang Y
    Coron Artery Dis; 2013 Jan; 24(1):16-22. PubMed ID: 23168569
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of elevated HbA1c on long-term mortality in patients presenting with acute myocardial infarction in daily clinical practice: insights from a 'real world' prospective registry of the Zwolle Myocardial Infarction Study Group.
    Hermanides RS; Kennedy MW; Kedhi E; van Dijk PR; Timmer JR; Ottervanger JP; Dambrink JH; Gosselink AM; Roolvink V; Miedema K; Slingerland RJ; Koopmans P; Bilo HJ; van 't Hof AW
    Eur Heart J Acute Cardiovasc Care; 2020 Sep; 9(6):616-625. PubMed ID: 31124695
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glycosylated hemoglobin is associated with decreased endothelial function, high inflammatory response, and adverse clinical outcome in non-diabetic STEMI patients.
    Moura FA; Figueiredo VN; Teles BS; Barbosa MA; Pereira LR; Costa AP; Carvalho LS; Cintra RM; Almeida OL; Quinaglia E Silva JC; Nadruz Junior W; Sposito AC;
    Atherosclerosis; 2015 Nov; 243(1):124-30. PubMed ID: 26385505
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic value of admission plasma glucose and HbA in acute myocardial infarction.
    Hadjadj S; Coisne D; Mauco G; Ragot S; Duengler F; Sosner P; Torremocha F; Herpin D; Marechaud R
    Diabet Med; 2004 Apr; 21(4):305-10. PubMed ID: 15049930
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Haemoglobin A(1c) , acute hyperglycaemia and short-term prognosis in patients without diabetes following acute ST-segment elevation myocardial infarction.
    Liu Y; Yang YM; Zhu J; Tan HQ; Liang Y; Li JD
    Diabet Med; 2012 Dec; 29(12):1493-500. PubMed ID: 22413832
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Impact of admission blood glucose on prognosis of ST-segment elevation myocardial infarction patients with or without known diabetes].
    Liu Y; Yang YM; Zhu J; Tan HQ; Liang Y; Liu LS; Li Y
    Zhonghua Xin Xue Guan Bing Za Zhi; 2009 Jul; 37(7):590-4. PubMed ID: 19961726
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effect of admission blood glucose levels on the short term mortality in patients with acute ST-segment elevation myocardial infarction].
    Yang YM; Liu Y; Zhu J; Tan HQ; Liang Y; Li Y; Li JD; Zhang Y; Liu LS
    Zhonghua Yi Xue Za Zhi; 2009 May; 89(18):1230-3. PubMed ID: 19595174
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In patients with ST-segment elevation myocardial infarction with cardiogenic shock treated with percutaneous coronary intervention, admission glucose level is a strong independent predictor for 1-year mortality in patients without a prior diagnosis of diabetes.
    Vis MM; Sjauw KD; van der Schaaf RJ; Baan J; Koch KT; DeVries JH; Tijssen JG; de Winter RJ; Piek JJ; Henriques JP
    Am Heart J; 2007 Dec; 154(6):1184-90. PubMed ID: 18035093
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic value of glycated hemoglobin among patients with ST-segment elevation myocardial infarction: a systematic review and meta-analysis.
    Li G; Hou X; Li Y; Zhang P; Zhao Q; Li J; Shi J
    Clin Chem Lab Med; 2017 Jul; 55(8):1090-1099. PubMed ID: 27816956
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hemoglobin A1c is a better predictor of prognosis following the non-ST elevation acute coronary syndrome than fasting and admission glucose.
    Kmet M; Rajer B; Pernat A
    Wien Klin Wochenschr; 2014 Mar; 126(5-6):156-62. PubMed ID: 24297265
    [TBL] [Abstract][Full Text] [Related]  

  • 15. General glycosylated hemoglobin goals potentially increase myocardial infarction severity in diabetes patients with comorbidities: Insights from a nationwide multicenter study.
    Che Q; Zhang Y; Wang J; Wan Z; Fu X; Chen J; Yan H; Chen Y; Ge J; Chen D; Huo Y
    J Diabetes Investig; 2020 Nov; 11(6):1498-1506. PubMed ID: 32383543
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association between HbA1c levels with severity of coronary artery disease and short-term outcomes of acute ST-elevation myocardial infarction in nondiabetic patients.
    Ghaffari S; Niafar F; Separham A; Niafar M; Pourafkari L; Nader ND
    Ther Adv Cardiovasc Dis; 2015 Oct; 9(5):305-13. PubMed ID: 25976908
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The value of admission glycosylated hemoglobin level in patients with acute myocardial infarction.
    Cakmak M; Cakmak N; Cetemen S; Tanriverdi H; Enc Y; Teskin O; Kilic ID
    Can J Cardiol; 2008 May; 24(5):375-8. PubMed ID: 18464942
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glycated hemoglobin vs fasting plasma glucose as a predictor of left ventricular dysfunction after ST-elevation myocardial infarction.
    Tsai JP; Tian J; Wang WY; Ng AC
    Can J Cardiol; 2015 Jan; 31(1):44-9. PubMed ID: 25547549
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of admission glucose profile and hemoglobin A1c on complications of acute myocardial infarction in diabetic patients.
    Vujosevic S; Radojevic N; Belada N
    Eur Rev Med Pharmacol Sci; 2013 May; 17(9):1252-7. PubMed ID: 23690196
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of admission plasma glucose level on short- and long-term prognosis in patients with ST-segment elevation myocardial infarction.
    Mladenović V; Zdravković V; Jović M; Vucić R; Irić-Cupić V; Rosić M
    Vojnosanit Pregl; 2010 Apr; 67(4):291-5. PubMed ID: 20465157
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.